Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders. The company was founded in 2021 and is headquartered in Guilford, Connecticut, United States.

Guilford, CT, USA

Invea Therapeutics

Bioscience

Connecticut Innovations provides strategic capital and operational insight to push the frontiers of high-tech industries such as energy, biotechnology, information technology, and photonics. Over the years, CI has helped over 100 emerging companies research, develop, and market new products and services. This activity has attracted over $1 billion dollars in additional investments from private equity providers. CI has brought the State of Connecticut over $510 million in Gross State Profit and over 5,000 additional job-years.

Career Opportunities